Tim Harris

Tim Harris is a seasoned professional in the biotechnology and pharmaceutical sectors, currently serving as a Venture Partner at SV Health Investors since June 2016. Previously, Tim held the position of EVP Corporate Development at Repertoire Immune Medicines from April 2020 to April 2022 and served as EVP R&D at Bioverativ, a Sanofi company, from April 2016 to December 2018. Prior experience includes serving as SVP of Precision Medicine at Biogen from June 2011 to March 2016 and as CTO at AIC Frederick from January 2007 to May 2011. Tim Harris earned a PhD and DSc in Biochemistry from the University of Birmingham, where studies took place from January 1968 to January 1974.